Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page
- Check4 days agoChange DetectedThe revision tag changes from v3.6.5 to v3.6.6. This indicates an incremental backend or documentation update without altering user-facing content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page's content/metadata.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, signaling a minor update to the page's metadata.SummaryDifference0.0%

- Check61 days agoChange DetectedA bibliographic note citing Sindher et al. on the management of gastrointestinal symptoms during oral immunotherapy was added, including PubMed attribution. The revision history was updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision metadata updated from v3.6.0 to v3.6.2, indicating a minor patch-level update. The change does not affect displayed content or functionality.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page adds recruitment-status text and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the Intervention/Treatment label and the revision/version from v3.5.5 to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.